G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Thailand Country Customs Leader

Full-TimeUpdated on 10/15/2026
No salary listed
Senior, Expert
Bachelor's
Bangkok, Thailand
In Person
Operations & LogisticsLogistics & Transportation

About the job

Requirements
  • A bachelor's degree in Customs, International Trade, Supply Chain, Logistics, Business, Finance, Law, Engineering, or a related discipline.
  • 8–10+ years of experience in customs operations, trade compliance, international trade, or logistics within a multinational business environment.
  • Strong working knowledge of Thailand Customs regulations, HS classification, customs valuation, country of origin, Free Trade Agreements, permits and licensing requirements, and customs audit processes.
  • Demonstrated experience managing customs brokers and external service providers.
  • Experience supporting customs audits, compliance reviews, and regulatory interactions.
  • Demonstrated compliance mindset, analytical capability, and process improvement experience.
  • Strong stakeholder management and influencing skills.
  • Fluency in written and spoken Thai and English.
  • Proficiency in Microsoft Office applications, particularly Excel, PowerPoint, and Word.
Responsibilities
  • Execute and govern day-to-day import customs operations in compliance with Thailand Customs regulations, GE HealthCare Customs Enterprise Standards, and applicable company policies and procedures.
  • Ensure pre-declaration controls are performed, including verification of customs valuation, HS classification, country of origin, permits, licenses, and other government agency requirements prior to customs declaration.
  • Own and manage customs broker, express carrier, and service provider performance, ensuring adherence to GE HealthCare compliance and operational requirements.
  • Serve as the primary customs operations point of contact for Thailand Customs authorities and coordinate responses to customs inquiries, inspections, and operational escalations.
  • Coordinate with Thailand Customs, Port FDA, and other government agencies on import compliance matters, inspections, regulatory requirements, and operational issue resolution.
  • Partner with Regulatory Affairs, Logistics, brokers, and relevant authorities to ensure timely and compliant import clearance of products subject to Thailand FDA controls, Port FDA requirements, and other government agency requirements, minimizing import delays and supply chain disruptions.
  • Manage customs facilitation and duty optimization programs, including Free Trade Agreements, advance rulings, duty exemption programs, and other approved customs initiatives.
  • Partner with cross-functional teams including Logistics, OTR, GSPO, Service, Finance, Tax, Legal, Regulatory Affairs, and Quality to proactively resolve customs-related operational challenges and minimize clearance delays.
  • Execute customs compliance policies, standard operating procedures, work instructions, and governance requirements at the country level.
  • Identify customs compliance risks and develop corrective and preventive actions to mitigate identified exposures.
  • Lead country-level preparation and support for internal audits, post-clearance reviews, and external customs audits, including responses to Customs and government authority inquiries.
  • Monitor customs and other government agency compliance requirements affecting imports, including Thailand FDA-related import controls, and ensure appropriate operational controls and broker instructions are maintained.
  • Evaluate customs controls and drive sustainable process improvements and compliance enhancements.
  • Ensure accurate recordkeeping, document retention, and compliance reporting in accordance with statutory and GE HealthCare requirements.
  • Prepare periodic customs metrics and reports covering duty spend, compliance performance, declaration quality, audit status, risks, opportunities, savings, and value creation.
  • Resolve routine customs issues and manage non-standard operational escalations involving classification, valuation, origin, permits, broker performance, and customs clearance challenges.
  • Apply professional judgment within established regulatory and company frameworks to develop compliant and practical business solutions.
  • Escalate high-risk, precedent-setting, or policy-sensitive matters to APAC Customs Leadership and relevant functional experts as appropriate.
  • Provide customs advisory support, training, and guidance to internal stakeholders on customs regulations, compliance requirements, and operational processes.
  • Coordinate with APAC and Global Customs teams on regional customs initiatives, compliance programs, system enhancements, and process improvements.
  • Build and maintain effective working relationships with customs authorities, brokers, external advisors, industry associations, and other external partners.
  • Support regional customs initiatives related to compliance excellence, operational efficiency, audit readiness, and duty optimization.
  • Communicate effectively with internal stakeholders, brokers, service providers, regulatory authorities, and government agencies in both Thai and English.
  • Provide customs subject matter expertise and country-level functional leadership to support capability building and operational excellence.
  • Where applicable, coach and develop customs personnel, strengthen functional capabilities, and promote a culture of compliance, accountability, and continuous improvement.
  • Drive a culture of proactive compliance, operational excellence, and continuous improvement across customs operations and external service providers.
Desired Qualifications
  • Thailand Customs professional certification, accreditation, or customs-related qualification.
  • Experience in medical devices, healthcare, life sciences, or other highly regulated industries.
  • Hands-on experience with Free Trade Agreements, customs audits, advance rulings, duty exemption programs, and customs compliance initiatives.
  • Experience participating in regional or global customs projects.
  • Previous leadership, coaching, or people management experience.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.

Yahoo Finance
Sep 15th, 2026
GE HealthCare launches AI tool to forecast hospital capacity bottlenecks 72 hours ahead

GE HealthCare has launched CareIntellect for Operations, an AI-powered software application that helps health systems forecast capacity constraints up to 72 hours ahead. The solution analyses hundreds of patient and operational data points to predict bottlenecks and recommend actions to optimise capacity and throughput. The Queen's Health Systems and Duke Health will be the first to implement the application. It uses two proprietary AI models: the Pressure Forecast model, which predicts resource constraints across hospitals and departments, and the Estimated Day of Discharge model, which predicts when patients will be discharged. The tool addresses operational challenges as US inpatient volumes rose 5.3% in 2025, requiring health systems to manage increased demand whilst facing staffing shortages and rising costs.

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.